Liverpool John Moores University are currently recruiting participants to take part in a research study looking at the effectiveness of a mindfulness-based intervention in preventing the development of persistent post-surgical pain (PPSP) following hysterectomy surgery.
A new study is coming soon for Post-menopausal Females and Sterilised Females via Bilateral Oophorectomy. Please read the following information carefully. If you are potentially interested in the trial, please respond to this email or call the Covance Clinical Research Recruitment Team between 09.00am – 19.00pm on 0113 3945200 or on 0800 591570
There are very real reasons why taking part in hysterectomy research is vital and the biggest reason is because there is so little of it, by comparison to other types of surgery and condition; yet it is still one of the most commonly performed operations on women the world over. Lucine Women is running a new hysterectomy survey and the more information that is shared the better, you can find out all about it here and then follow the link to the survey itself too: http://www.hormonesmatter.com/hysterectomy-survey/
The total number of hysterectomies performed in UK NHS hospitals in 2011/2012 is 56,976. Of this, at least 35,396 are abdominal hysterectomies and at least 18,154 are vaginal hysterectomies. The reason for the possible disparity is that it isn’t possible to break down the overall figure for Scotland, which accounts for 3,426 hysterectomies.
Dutch researchers have reported on a four year project to follow a group of women who had received either an abdominal hysterectomy or a laparoscopic hysterectomy for benign conditions to find out if there was any difference in their quality of life post operatively.
Did you know that : Firstly - Endometriosis is only possible to diagnose through surgery , some consultants are now using MRI scans but they are not as affective - even following surgery only 1 in 3 women will…
Researchers in the United States have found that women who have a hysterectomy that also removes the ovaries have a reduced risk of developing ovarian cancer, other cancers, and heart disease. Surprisingly, the rate of hip fractures (due to osteoporosis…
Herceptin (trastuzumab) has been the media’s choice in recent days to help all women coping with breast cancer. Following a successful campaign in the national press, on television and in the radio herceptin has now been licensed for use by…